NORTHWEST BIOTHERAPEUTICS INC Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Northwest Biotherapeutics Inc quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2024.
  • Northwest Biotherapeutics Inc Operating Lease, Payments for the quarter ending March 31, 2024 was $241K, a 7.11% increase year-over-year.
  • Northwest Biotherapeutics Inc annual Operating Lease, Payments for 2023 was $846K, a 6.93% decline from 2022.
  • Northwest Biotherapeutics Inc annual Operating Lease, Payments for 2022 was $909K, a 4.97% increase from 2021.
  • Northwest Biotherapeutics Inc annual Operating Lease, Payments for 2021 was $866K, a 12.8% decline from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $241K +$16K +7.11% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q1 2023 $225K -$14K -5.86% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q1 2022 $239K -$16K -6.28% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 $255K +$11K +4.51% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $244K +$244K Jan 1, 2020 Mar 31, 2020 10-Q 2020-06-24
Q1 2019 $0 Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.